Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Chimeric Therapeutics Ltd. has announced the issuance of 55 million unquoted equity securities, set to expire on various dates, indicating an active move in the capital markets. This development could influence the company’s stock activity on the ASX, drawing attention from investors focused on biotech innovations.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.